Loading provider…
Loading provider…
Hematology & Oncology Physician in Baltimore, MD
NPI: 1114001138Primary Practice Location
UNIVERSITY OF MARYLAND MEDICAL CENTER
22 S Greene St, Baltimore, MD
Primary Employer
University of Maryland Oncology Associates, PA
umms.org
HQ Phone
Get MD Mehmet's Phone Numberphone_androidMobile
Get MD Mehmet's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardAR State Medical License
MD State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 113 | 240 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 48 | 130 |
| 3 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 34 | 196 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 28 | 30 |
| 5 | 99442Physician telephone patient service, 11-20 minutes of medical discussion | 23 | 25 |
Authors: Jason Molitoris, Justin Malinou, Jean Yared, Saurabh Dahiya, Aaron Rapoport, Ali Bukhari, Santanu Samanta, Djordje Atanackovic
Journal: Transplant Proc
Publication Date: 2023-01-11
High SOX2 levels predict better outcome in non-small cell lung carcinomas.
Authors: Vamsidhar Velcheti
Publication Date: 2012-12-27
Authors: Ashraf Badros, Aaron Rapoport
Journal: Clin Lymphoma Myeloma Leuk
Publication Date: 2022-03-28
Lead Sponsor: GlaxoSmithKline
Intervention / Treatment: DRUG: Belantamab mafodotin
Lead Sponsor: GlaxoSmithKline
Intervention / Treatment: DRUG: Belantamab mafodotin